Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 1
2000 1
2001 1
2002 1
2004 1
2005 2
2006 2
2007 1
2008 6
2009 8
2010 6
2011 9
2012 8
2013 4
2014 5
2015 11
2016 12
2017 12
2018 10
2019 4
2020 2
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 23829368

94 results
Results by year
Filters applied: . Clear all
Page 1
Cannabinoids and schizophrenia: therapeutic prospects.
Robson PJ, Guy GW, Di Marzo V. Robson PJ, et al. Curr Pharm Des. 2014;20(13):2194-204. doi: 10.2174/13816128113199990427. Curr Pharm Des. 2014. PMID: 23829368 Review.
Cannabinoids and Schizophrenia: Risks and Therapeutic Potential.
Manseau MW, Goff DC. Manseau MW, et al. Neurotherapeutics. 2015 Oct;12(4):816-24. doi: 10.1007/s13311-015-0382-6. Neurotherapeutics. 2015. PMID: 26311150 Free PMC article. Review.
Therapeutic Potential of Cannabinoids in Psychosis.
Leweke FM, Mueller JK, Lange B, Rohleder C. Leweke FM, et al. Biol Psychiatry. 2016 Apr 1;79(7):604-12. doi: 10.1016/j.biopsych.2015.11.018. Epub 2015 Nov 28. Biol Psychiatry. 2016. PMID: 26852073 Review.
The Role of the Endocannabinoid System in the Brain-Gut Axis.
Sharkey KA, Wiley JW. Sharkey KA, et al. Gastroenterology. 2016 Aug;151(2):252-66. doi: 10.1053/j.gastro.2016.04.015. Epub 2016 Apr 29. Gastroenterology. 2016. PMID: 27133395 Free PMC article. Review.
Endocannabinoid system dysfunction in mood and related disorders.
Ashton CH, Moore PB. Ashton CH, et al. Acta Psychiatr Scand. 2011 Oct;124(4):250-61. doi: 10.1111/j.1600-0447.2011.01687.x. Epub 2011 Mar 9. Acta Psychiatr Scand. 2011. PMID: 21916860 Review.
94 results
Jump to page
Feedback